Search results for: Haemophilia
Filter search results
AIDS Virus: Forecasting Its Impact
1 December 1986
…been predominantly seen in a limited number of high risk groups – homosexual males, intravenous drug abusers and haemophiliacs. The overall prevalence of infection among these groups is not accurately…
ISPOR Issue Panel Roundup: Are Our HTA Methods Fit for Purpose for Gene Therapies?
6 June 2022
…Advancement) also discussed the role of real-world evidence from a patient’s perspective, applying his experience of haemophilia. One of his key points was about ensuring that the data generated extends…
OHE Lunchtime Seminar: Early Experience with HTA of Gene Therapies in the US: Pricing and Paying for Cures
21 October 2018, 11:00pm
…haemophilia, sickle cell disease, and numerous other genetically-based conditions. Individually, each treatment will be extremely expensive, and in the aggregate their costs are projected to have a substantial impact on…
OHE Lunchtime Seminars: Steven Pearson and Janel Hanmer
4 October 2018
…be able to manage a growing number of drugs offering potential cures for a wide range of illnesses. The innovation pipeline includes potential cures for haemophilia, sickle cell disease, and…
Pricing and Paying for Cures: Early Experience with HTA of Gene Therapy in the USA
28 February 2019
…treatment for haemophilia A. The prior standard of care (bypassing agent prophylaxis) has an expected lifetime cost per patient of $99m. Cost-effectiveness analysis would suggest a price tag of up…